US Frontotemporal Dementia Market to Witness Healthy Growth Rate until 2025
Increasing funding by government for healthcare sector and growing number of dementia cases to drive United States frontotemporal dementia market According to TechSci Research report, “ United States Frontotemporal Dementia Market By Drug Class Type (Antidepressants (Fluoxetine, Fluvoxamine, Sertraline, Paroxetine, Citalopram, Bupropion, Mitrazepine), Antipsychotics (Olanzepine, Quetiapine, Ziprasidone, Aripiprazole, Risperidone, Paliperidone), By Disease Type (Behavior Variant Frontotemporal Dementia (bvFTD), Primary Progressive Aphasia (PPA), Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy, Others), By End User (Hospitals, Specialty Clinics, Others), By Region, Forecast & Opportunities, 2025 ” , the market is expected to undergo significant growth during the forecast period owing to increasing life expectancy rate in the country and growing geriatric population, which is more prone to neurodegenerative dise...